Clinical trial of a potassium-sparing saluretic pyrazine derivative (MK-870).
D000328:Adult; D000368:Aged; D002245:Carbon Dioxide / Q000097:blood; D002712:Chlorides / Q000652:urine; D003401:Creatine / Q000097:blood; D004232:Diuretics / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood / Q000378:metabolism* / Q000652:urine; D011719:Pyrazines / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood / Q000652:urine; D014527:Uric Acid / Q000097:blood
D002712:Chlorides; D004232:Diuretics; D011719:Pyrazines; D002245:Carbon Dioxide; D014527:Uric Acid; D012964:Sodium; D003401:Creatine; D011188:Potassium